THE CONCURRENCE OF GOUT, PYROPHOSPHATE ARTHROPATHY, MÖ NCKEBERG'S CALCIFICATION, AND OSTEOPOROSIS IN A FEMALE PATIENT WITH A KIDNEY GRAFT: CASE DESCRIPTION

QR Code

THE CONCURRENCE OF GOUT, PYROPHOSPHATE ARTHROPATHY, MÖ NCKEBERG'S CALCIFICATION, AND OSTEOPOROSIS IN A FEMALE PATIENT WITH A KIDNEY GRAFT: CASE DESCRIPTION

Saved in:

Bibliographic Details
Main Authors:	Igor Sergeyevich Denisov, M S Eliseyev, V G Barskova, И С Дыдыкина, А В Смирнов, Л А Божьева, S G Radenska-Lopovok, Р А Осипянц, Е И Маркелова
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2012-12-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1585
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Use of meloxicam (Amelotex®) in patients with pyrophosphate arthropathy
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-09-01)

Comparison of three radiodiagnostic techniques for pyrophosphate arthropathy
by: Fatima Magomedovna Kudayeva, et al.
Published: (2012-06-01)

PYROPHOSPHATE ARTHROPATHY IS A RHEUMATOLOGICAL ICEBERG SYNDROME: TIME TO REASSESS ITS IMPORTANCE IN JOINT DISEASES
by: Viktoria Georgiyevna Barskova, et al.
Published: (2010-06-01)

A mask of pyrophosphate arthropathy: disclosure
by: E V Il'inykh, et al.
Published: (2011-06-01)

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2012-09-01)

Risk factors for gout: Gender differences
by: Maxim Sergeyevich Eliseyev, et al.
Published: (2011-12-01)

Experience in treating a gout patient with adrenal insufficiency
by: Viktoria Georgiyevna Barskova, et al.
Published: (2012-12-01)

Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
by: M S Eliseyev, et al.
Published: (2012-03-01)

USE OF REMICADE® IN PATIENTS WITH CHRONIC TOPHACEOUS GOUT: THEORETICAL RATIONALE AND ASSESSMENT OFOWN EXPERIENCE
by: M S Eliseyev, et al.
Published: (2009-06-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Prevalence and factors associated to calcium pyrophosphate arthritis in patients with gout
by: Fernando Perez-Ruiz, et al.
Published: (2024-09-01)

MULTIMODALITY THERAPY FOR CHRONIC TOPHACEOUS GOUT
by: M S Eliseev, et al.
Published: (2008-12-01)

Use of etoricoxib in patients with gout in real clinical practice
by: M S Eliseyev, et al.
Published: (2013-06-01)

Use of Blemaren citrate formula in gout patients with nephrolithiasis
by: M S Eliseev, et al.
Published: (2008-09-01)

ATYPICAL GOUT: SPINAL TOPHACEOUS INJURY
by: Maksim Sergeevich Eliseev, et al.
Published: (2013-12-01)

Calcification of coronary arteries in patients with calcium pyrophosphate crystal deposition disease and knee osteoarthritis
by: M. S. Eliseev, et al.
Published: (2021-09-01)

THE PREVALENCE AND CLINICAL FEATURES OF GOUT AND CALCIUM PYROPHOSPHATE DEPOSITION DISEASE IN PATIENTS WITH ACUTE ARTHRITIS
by: M. S. Eliseev, et al.
Published: (2015-09-01)

Arterial hypertension in gout patients: Pathogenesis bases, clinical value, diagnosis
by: E I Markelova, et al.
Published: (2012-12-01)

OSTEOPOROSIS IN CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: S A Vladimirov, et al.
Published: (2013-02-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

Use of urisan in gout
by: A E Il'ina, et al.
Published: (2008-03-01)

Diagnosis of gout (a lecture)
by: V G Barskova
Published: (2012-08-01)

Use of meloxicam (Amelotex®) in patients with chronic gout to prevent
by: M S Eliseyev, et al.
Published: (2011-12-01)

THE CLINICAL MANIFESTATIONS OF CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION DISEASE
by: F. M. Kudaeva, et al.
Published: (2014-09-01)

European League Against Rheumatism recommendations for terminologyand diagnosis of calcium pyrophosphate crystal deposition disease: Expert comment
by: V G Barskova, et al.
Published: (2011-06-01)

European League Against Rheumatism recommendations for terminology and diagnosis of calcium pyrophosphate crystal deposition disease: An expert's comments
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-09-01)

On the diagnosis and coding of reactive arthropathies
by: R. M. Balabanova
Published: (2020-05-01)

Fibrosing arthropathy in juvenile scleroderma
by: D. A. Dibrov, et al.
Published: (2021-04-01)

Rasshifrovka diagnoza s pomoshch'yupolyarizatsionnoy mikroskopii posle 12 let sushchestvovaniya artrita(opisanie sluchaya)
by: Maksim Sergeyevich Eliseyev, et al.
Published: (2011-12-01)

SIGNIFICANCE OF DIET AND DIETARY SUPPLEMENTS IN GOUT
by: A E Il'ina, et al.
Published: (2008-12-01)

SEVERE CONCURRENT BLUNT ABDOMEN TRAUMA: SPECIFIC COURSE OF TRAUMATIC DISEASE (REPORT ONE)
by: I. M. Sаmokhvаlov, et al.
Published: (2018-07-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Gout, hyperuricemia and cardiovascular risk
by: A E Iljina, et al.
Published: (2009-02-01)

The specific features of arthropathy in Whipple's disease
by: I V Maev, et al.
Published: (2008-09-01)

Hemophilic Arthropathy—Pathophysiology and Advances in Treatment
by: Katarina Kovač, et al.
Published: (2025-04-01)

Alcohol and the clinical picture of gout
by: V G Barskova, et al.
Published: (2007-09-01)

Actovegin administration in patients with ulcerated gout tophuses
by: M S Eliseev, et al.
Published: (2005-10-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

Use of citrate formulas in patients with gout and nephrolithiasis
by: F M Kudaeva, et al.
Published: (2007-09-01)